Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical application of imperatorin in treatment of hypertension complicated with myocardial hypertrophy and heart protection

A technology for imperatorin and cardiac hypertrophy, which can be used in drug combinations, active ingredients of heterocyclic compounds, cardiovascular system diseases, etc., and can solve problems such as toxic and side effects

Inactive Publication Date: 2012-02-15
XI AN JIAOTONG UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, the commonly used calcium antagonists are obtained through chemical synthesis, and all of them have certain toxic and side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical application of imperatorin in treatment of hypertension complicated with myocardial hypertrophy and heart protection
  • Pharmaceutical application of imperatorin in treatment of hypertension complicated with myocardial hypertrophy and heart protection
  • Pharmaceutical application of imperatorin in treatment of hypertension complicated with myocardial hypertrophy and heart protection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] The experiment aimed at the effect of imperatorin on hypertrophic cardiomyocytes after induction. Firstly, cardiomyocyte hypertrophy caused by Ang II was produced, and the primary cardiomyocytes of SD rats were obtained by enzymatic digestion. The experiments used 4-10 generation cells. Digest cardiomyocytes with 0.125% trypsin, count, make single cell suspension, and use 10 per well 4 Cells were seeded in a 24-well culture plate, 1 mL per well, and transferred into 37 °C CO 2 In the incubator, dosing was performed when the cells grew to 80% confluency. Cardiomyocytes were induced with 10, 1 and 0.1 μmol / L Ang II, 1 mL per well. At 37°C, 5% CO 2 and saturated humidity conditions, and at the same time each well was mixed with [ 3 H]-leucine continued to cultivate for 48h. Cardiomyocytes were induced with 10, 1 and 0.1 μmol / L Ang II for 48 hours. It was found that 1 μmol / L Ang II could significantly induce the protein synthesis of cardiomyocytes, and the effect was b...

Embodiment 2

[0014] Example 2: Effect of imperatorin on left heart hypertrophy and myocardial fibrosis in SHR rats

[0015] To test the effect of imperatorin on left heart hypertrophy and myocardial fibrosis in SHR rats, first investigate its effect on hypertrophy index, that is, imperatorin has a dose-dependent down-regulation of left heart hypertrophy index (LVW / BW) effect, and is superior to captopril. Compared with the SHR control group, the left ventricular weight (LVW) of the high-dose imperatorin group decreased significantly (P<0.01). Significant difference (P<0.001); the right ventricular weight (RVW) of each dose group of imperatorin did not decrease due to the decrease of left ventricular weight (LVW), see Table 1. The high-dose imperatorin group even raised the right ventricular index (RVW / BW) to a certain extent, making the heart composition ratio more reasonable.

[0016] Table 1

[0017]

[0018]

[0019] Note: ** P* P<0.05 vs SHR group.

[0020] The effect of the...

Embodiment 3

[0034] To test the relationship between the effect of imperatorin on myocardial hypertrophy and the pathway of NO, the animal model was first established by unilateral renal artery stenosis, that is, the mice were fasted for 12 hours before the operation and had free access to water. The next morning, the mice were anesthetized by intraperitoneal injection of 20% wulai sugar (5mL / Kg). After the mice had no blinking response, they were fixed on the operating table in a supine position, and the left abdomen was skinned. The operation area was about 1×1cm 2 , sterilize the skin with 1% iodine and 75% ethanol, respectively, and make an opening about 0.5 cm below the left rib, 1 cm parallel to the midline of the rib, and the size of the opening is about 1-2 cm, exposing the intra-abdominal organs. Use tweezers to pick up a small piece of sterile gauze, enter from the edge of the left abdominal cavity of the mouse, move the stomach and other organs above the left kidney to the right ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to pharmaceutical application of imperatorin in treatment of hypertension complicated with myocardial hypertrophy and heart protection. The imperatorin is furocoumarin compound imperatorin, which is derived from the extracts of traditional Chinese medicines dahurian angelica and cnidium fruit; and the imperatorin has no toxic or side effects when used for treating hypertension complicated with myocardial hypertrophy and heart protection related to NO way. Research shows that the imperatorin has treatment effect on hypertension complicated with myocardial hypertrophy, and has protection action on heart through NO way.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine extracts, and in particular relates to a medicinal use of imperatorin for hypertension combined with myocardial hypertrophy and heart protection. Background technique [0002] Hypertension is one of the most common cardiovascular and cerebrovascular diseases. Epidemiological surveys have shown that hypertension in my country has the characteristics of high prevalence, high disability rate, and high mortality rate. At the same time, the long course of hypertension, accompanied by complications in the later stage, is also the most important risk factor for coronary heart disease, stroke, and renal failure. Among them, left ventricular hypertrophy, as the main complication of hypertension, has attracted more and more attention. [0003] The treatment of hypertension includes drug therapy and non-drug therapy, among which drugs to lower blood pressure can effectively reduce the i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/37A61P9/12A61P9/00
Inventor 贺浪冲张燕曹艳君卢闻王嗣岑杨广德李西玲贺怀贞张杰
Owner XI AN JIAOTONG UNIV